Monoamine oxidase inhibitor toxicity: Difference between revisions

m (Rossdonaldson1 moved page MAOI Toxicity to Mono amine oxidase inhibitor toxicity)
Line 11: Line 11:
==Differential Diagnosis==
==Differential Diagnosis==
*Intoxications
*Intoxications
**Amphetamines
**[[Amphetamines]]
**Antimuscarinics
**[[Antimuscarinics]]
*Withdrawal states
*Withdrawal states
**Ethanol
**[[Ethanol withdrawal|Ethanol]]
**Clonidine
**Clonidine
**Beta-blockers
**Beta-blockers
*Medical conditions
*Medical conditions
**Heat stroke
**[[Heat stroke]]
**Hypoglycemia
**[[Hypoglycemia]]
**Hyperthyroidism
**[[Hyperthyroidism]]
*Adverse drug reactions
*Adverse drug reactions
**[[Malignant Hyperthermia]]
**[[Malignant Hyperthermia]]

Revision as of 03:59, 28 September 2015

Background

  • Mono Amine Oxidase Inhibitors (MAOI)
  • Used to treat depression and Parkinsonism (e.g. selegiline)
  • Lead to increased norepinephrine, serotonin, dopamine, tyramine
  • Toxicity often delayed 6-24 hours after ingestion

Clinical Features

Differential Diagnosis

Diagnosis

Treatment

  1. Gastric decontamination
  2. Supportive care
    • Hypertension
      • Treat only with short-acting agents: may develop precipitous hypotension
      • Phentolamine: 2.5-5mg IV bolus q15-15min; can also give as infusion 0.2-0.5mg/min
      • Nitroprusside: 1mcg/kg/min and titrate up
    • Hypotension: intravenous fluid +/- norepinephrine
    • Seizures: benzodiazepines are 1st line
    • Hyperthermia
      • Routine cooling measures
      • Consider paralysis if patient has persistent muscle rigidity

Disposition

  • Admit all patients for 24 hour observation to monitored setting

Prevention

  • Do not prescribe the following medications if a patient is taking a MAOI: meperidine, dextromethorphan, tramadol, propoxyphene, or cyclobenzaprine

See Also

References